IGBA taking action to tackle shortages of antibiotic medicines (December 2022)
The global generic medicines industry supplies most of the world’s antibiotic medicine and is aware of the current surge in demand of these products that is leading to shortages. The surge is driven by an unusually high rate of respiratory conditions and infections that are occurring as we exit the most acute phase of the Covid-19 pandemic and, in many countries, an unusually high rate of respiratory conditions and infections among children. Demand has also increased due to changes in prescribing protocols, leading to a much higher number of prescriptions being issued for certain antibiotic medicines.